Lista de obras -

A Decade of Blood Biomarkers for Alzheimer's Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication

artículo científico publicado en 2018

A GENOME-WIDE META-ANALYSIS OF PLASMA CLUSTERIN LEVELS IN THE CHARGE CONSORTIUM

A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer's Disease

artículo científico publicado en 2016

A Subset of Cerebrospinal Fluid Proteins from a Multi-Analyte Panel Associated with Brain Atrophy, Disease Classification and Prediction in Alzheimer's Disease

artículo científico publicado en 2015

A genetic risk factor for periodic limb movements in sleep

artículo científico publicado en 2007

A practical approach to the diagnosis and management of MELAS: case report and review

artículo científico publicado en 2002

A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease

scholarly article by Nicola Greenberg et al published April 2009 in Electrophoresis

APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging

artículo científico publicado en 2010

Abnormal gephyrin immunoreactivity associated with Alzheimer disease pathologic changes

artículo científico publicado en 2013

Aggregation properties of the small nuclear ribonucleoprotein U1-70K in Alzheimer disease

artículo científico publicado en 2014

Alzheimer risk variant CLU and brain function during aging

artículo científico publicado en 2012

Alzheimer's disease risk genes and the age-at-onset phenotype

artículo científico publicado en 2013

Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer's Disease

artículo científico publicado en 2016

Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: A nontargeted metabolomic study

artículo científico publicado en 2017

Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease

artículo científico publicado en 2010

BLOOD-BASED BIOMARKERS OF ALZHEIMER'S DISEASE PATHOLOGY AND COGNITIVE DECLINE IN NON-DEMENTED ELDERLY

scholarly article by Sarah Westwood et al published July 2014 in Alzheimer's and Dementia

Baseline cardiovascular risk predicts subsequent changes in resting brain function

artículo científico publicado en 2012

Blood glucose levels and cortical thinning in cognitively normal, middle-aged adults

artículo científico publicado en 2016

Blood metabolite markers of cognitive performance and brain function in aging

artículo científico publicado en 2015

Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals

artículo científico publicado en 2016

Blood-based biomarkers of Alzheimer's disease: challenging but feasible

artículo científico publicado en 2010

Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts

artículo científico publicado en 2015

Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression

artículo científico publicado en 2016

Deep proteomic network analysis of Alzheimer's disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease

artículo científico publicado en 2018

Diagnosis and management of MELAS.

artículo científico publicado en 2004

Do Extracellular Chaperone Proteins in Plasma have Potential as Alzheimer‘s Disease Biomarkers? ⬇️

artículo científico publicado el 1 de diciembre de 2010

Effect of complement CR1 on brain amyloid burden during aging and its modification by APOE genotype

artículo científico publicado en 2012

Evidence for brain glucose dysregulation in Alzheimer's disease

artículo científico publicado en 2017

Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease.

artículo científico publicado en 2013

Fulminant idiopathic intracranial hypertension

artículo científico publicado en 2007

Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging

scientific article published on September 2013

Hypertensive brainstem encephalopathy: clinical and radiographic features

artículo científico publicado en 2003

Identifying novel CSF markers of brain atrophy in Alzheimer's disease and mild cognitive impairment using a multiplex panel of analytes

Impaired glucose tolerance in midlife and longitudinal changes in brain function during aging

artículo científico publicado en 2013

Interleukin-6 is linked to longitudinal rates of cortical thinning in aging

artículo científico publicado en 2014

Longitudinal changes in cortical thickness associated with normal aging

artículo científico publicado en 2010

Metabolomic method: UPLC-q-ToF polar and non-polar metabolites in the healthy rat cerebellum using an in-vial dual extraction

artículo científico publicado en 2015

Midlife anticholinergic drug use, risk of Alzheimer's disease, and brain atrophy in community-dwelling older adults

artículo científico publicado en 2017

Obesity and Longer Term Risks of Dementia in 65-74 Year Olds

scholarly article by Kirsty Bowman et al published 1 May 2019 in Age and Ageing

Peril beyond the winner's curse: A small sample size is the bane of biomarker discovery

artículo científico publicado en 2017

Personality Change in the Preclinical Phase of Alzheimer Disease

artículo científico publicado en 2017

Pharmacologic inhibition of ROCK2 suppresses amyloid-β production in an Alzheimer's disease mouse model

artículo científico publicado en 2013

Plasma Biomarkers Associated With the Apolipoprotein E Genotype and Alzheimer Disease ⬇️

artículo científico publicado el 1 de octubre de 2012

Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of aging

artículo científico publicado en 2015

Plasma based markers of [11C] PiB-PET brain amyloid burden

artículo científico publicado en 2012

Plasma biomarkers of brain atrophy in Alzheimer's disease

artículo científico publicado en 2011

Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment

artículo científico publicado en 2011

Prevalence of dementia subtypes in United States Medicare fee-for-service beneficiaries, 2011-2013.

artículo científico publicado en 2016

Processing and memory for emotional and neutral material in amyotrophic lateral sclerosis

artículo científico publicado en 2012

Proteome-based identification of plasma proteins associated with hippocampal metabolism in early Alzheimer's disease

artículo científico publicado en 2008

Proteome-based plasma markers of brain amyloid-β deposition in non-demented older individuals

artículo científico publicado en 2010

Proteomics of Alzheimer's disease: understanding mechanisms and seeking biomarkers

artículo científico publicado en 2007

Rho-associated protein kinase 1 (ROCK1) is increased in Alzheimer's disease and ROCK1 depletion reduces amyloid-β levels in brain

artículo científico publicado en 2016

SPARCL1 Accelerates Symptom Onset in Alzheimer's Disease and Influences Brain Structure and Function During Aging

artículo científico publicado en 2017

Sex-Dependent Associations of Serum Uric Acid with Brain Function During Aging

artículo científico publicado en 2017

Soluble interleukin-6 receptor levels and risk of dementia: one more signpost on a long road ahead

artículo científico publicado en 2014

State- and trait-dependent associations of vitamin-D with brain function during aging

artículo científico publicado en 2015

The Utility of 11C-Arachidonate PET to Study in vivo Dopaminergic Neurotransmission in Humans ⬇️

artículo científico publicado el 14 de diciembre de 2011

U1 small nuclear ribonucleoproteins (snRNPs) aggregate in Alzheimer's disease due to autosomal dominant genetic mutations and trisomy 21.

artículo científico publicado en 2014

Understanding mechanisms and seeking cures for Alzheimer's disease: why we must be "extraordinarily diverse".

artículo científico publicado en 2017

Utility of the Malayalam translation of the 7- minute screen for Alzheimer's disease risk in an Indian community

artículo científico publicado en 2008

α2-macroglobulin in Alzheimer's disease: new roles for an old chaperone

artículo científico publicado en 2018

Lista de obras de

A Decade of Blood Biomarkers for Alzheimer's Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication

A GENOME-WIDE META-ANALYSIS OF PLASMA CLUSTERIN LEVELS IN THE CHARGE CONSORTIUM

A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer's Disease

A Subset of Cerebrospinal Fluid Proteins from a Multi-Analyte Panel Associated with Brain Atrophy, Disease Classification and Prediction in Alzheimer's Disease

A genetic risk factor for periodic limb movements in sleep

A practical approach to the diagnosis and management of MELAS: case report and review

A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease

APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging

Abnormal gephyrin immunoreactivity associated with Alzheimer disease pathologic changes

Aggregation properties of the small nuclear ribonucleoprotein U1-70K in Alzheimer disease

Alzheimer risk variant CLU and brain function during aging

Alzheimer's disease risk genes and the age-at-onset phenotype

Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer's Disease

Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: A nontargeted metabolomic study

Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease

BLOOD-BASED BIOMARKERS OF ALZHEIMER'S DISEASE PATHOLOGY AND COGNITIVE DECLINE IN NON-DEMENTED ELDERLY

Baseline cardiovascular risk predicts subsequent changes in resting brain function

Blood glucose levels and cortical thinning in cognitively normal, middle-aged adults

Blood metabolite markers of cognitive performance and brain function in aging

Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals

Blood-based biomarkers of Alzheimer's disease: challenging but feasible

Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts

Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression

Deep proteomic network analysis of Alzheimer's disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease

Diagnosis and management of MELAS.

Do Extracellular Chaperone Proteins in Plasma have Potential as Alzheimer‘s Disease Biomarkers? ⬇️

Effect of complement CR1 on brain amyloid burden during aging and its modification by APOE genotype

Evidence for brain glucose dysregulation in Alzheimer's disease

Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease.

Fulminant idiopathic intracranial hypertension

Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging

Hypertensive brainstem encephalopathy: clinical and radiographic features

Identifying novel CSF markers of brain atrophy in Alzheimer's disease and mild cognitive impairment using a multiplex panel of analytes

Impaired glucose tolerance in midlife and longitudinal changes in brain function during aging

Interleukin-6 is linked to longitudinal rates of cortical thinning in aging

Longitudinal changes in cortical thickness associated with normal aging

Metabolomic method: UPLC-q-ToF polar and non-polar metabolites in the healthy rat cerebellum using an in-vial dual extraction

Midlife anticholinergic drug use, risk of Alzheimer's disease, and brain atrophy in community-dwelling older adults

Obesity and Longer Term Risks of Dementia in 65-74 Year Olds

Peril beyond the winner's curse: A small sample size is the bane of biomarker discovery

Personality Change in the Preclinical Phase of Alzheimer Disease

Pharmacologic inhibition of ROCK2 suppresses amyloid-β production in an Alzheimer's disease mouse model

Plasma Biomarkers Associated With the Apolipoprotein E Genotype and Alzheimer Disease ⬇️

Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of aging

Plasma based markers of [11C] PiB-PET brain amyloid burden

Plasma biomarkers of brain atrophy in Alzheimer's disease

Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment

Prevalence of dementia subtypes in United States Medicare fee-for-service beneficiaries, 2011-2013.

Processing and memory for emotional and neutral material in amyotrophic lateral sclerosis

Proteome-based identification of plasma proteins associated with hippocampal metabolism in early Alzheimer's disease

Proteome-based plasma markers of brain amyloid-β deposition in non-demented older individuals

Proteomics of Alzheimer's disease: understanding mechanisms and seeking biomarkers

Rho-associated protein kinase 1 (ROCK1) is increased in Alzheimer's disease and ROCK1 depletion reduces amyloid-β levels in brain

SPARCL1 Accelerates Symptom Onset in Alzheimer's Disease and Influences Brain Structure and Function During Aging

Sex-Dependent Associations of Serum Uric Acid with Brain Function During Aging

Soluble interleukin-6 receptor levels and risk of dementia: one more signpost on a long road ahead

State- and trait-dependent associations of vitamin-D with brain function during aging

The Utility of 11C-Arachidonate PET to Study in vivo Dopaminergic Neurotransmission in Humans ⬇️

U1 small nuclear ribonucleoproteins (snRNPs) aggregate in Alzheimer's disease due to autosomal dominant genetic mutations and trisomy 21.

Understanding mechanisms and seeking cures for Alzheimer's disease: why we must be "extraordinarily diverse".

Utility of the Malayalam translation of the 7- minute screen for Alzheimer's disease risk in an Indian community

α2-macroglobulin in Alzheimer's disease: new roles for an old chaperone